You're listening to Plenary Session.

This week on Plenary Session, I'm in the new HQ down on the waterfront.

I misstate that one time during the podcast.

And I'm here in the studio with Dr. Cliff Hudders, who's the CEO of ASCO and former

section chief of breast oncology at Memorial Sloan Kettering. Dr. Cliff Hudders, who's the CEO of ASCO and former section chief of breast

oncology at Memorial Sloan Kettering. Dr. Hudders and I had a wide-ranging discussion about many

issues. I hope you find it of interest. I'm going to cut right to it. Stay tuned for later this week

when I'm going to take a deep dive into precision oncology in a forthcoming episode. But for now,

the interview with Dr. Hudders.

But first, a plug. If you like this podcast, do us a favor and recommend it to a friend.

Plenary Session wants to grow its audience and the best way to do so is to get a personal recommendation from someone

you know or trust. So recommend it to someone and have them check out an episode. Also, consider

supporting us on Patreon. Patreon.com allows you to support artists or podcasts that you appreciate,

and if you like this podcast, that's a great way to show your support. Finally, if you haven't yet gone on to the iTunes store and written us a review, we greatly

appreciate it.

Tell us what you think about this podcast and give us five stars if we've earned it.

All right.

I'm back here in Plenary Session Hsu with Dr. Cliff Huddis.

Dr. Huddders is CEO of

ASCO. And prior to that, he was the chief of breast oncology at Memorial Sloan Kettering,

a role he held from 1998 to 2016. He has been at ASCO just the last few years and leads the organization.

Dr. Huddis, thanks so much for coming here to Plenary Session H.Q. It's a treat to join you here. Thank you.

...